Focus

Pfizer

Pfizer Filing Shows 70 Percent Decline in COVID Vaccine Revenue

Pfizer Filing Shows 70 Percent Decline in COVID Vaccine Revenue
Feb 29
|

Pfizer and Moderna COVID Vaccines’ Efficacy Exaggerated, Effectiveness ‘Well Below’ 50 Percent, Researchers Say

Pfizer and Moderna COVID Vaccines’ Efficacy Exaggerated, Effectiveness ‘Well Below’ 50 Percent, Researchers Say
Feb 26
|

Frequent COVID Boosters in Immunocompromised ‘May Be Causing More Harm Than Benefit,’ New Review Suggests

Frequent COVID Boosters in Immunocompromised ‘May Be Causing More Harm Than Benefit,’ New Review Suggests
Feb 08
|
Denied and Attacked: Vaccine-Injured Health Care Workers Demand to Be Heard, Acknowledged, Compensated
Feb 02
|

FDA Revises Emergency Use of Paxlovid

FDA Revises Emergency Use of Paxlovid
Jan 29
|

Majority of Americans Believe COVID Shots Cause ‘Unexplained Deaths’

Majority of Americans Believe COVID Shots Cause ‘Unexplained Deaths’
Jan 29
|

Health Canada Responds to MP’s Questions on SV40 DNA Sequence in Pfizer Vaccine

Health Canada Responds to MP’s Questions on SV40 DNA Sequence in Pfizer Vaccine
Jan 02
|

People Who Received Older Pfizer COVID Vaccines Had Similar Outcomes as Unvaccinated: Study

People Who Received Older Pfizer COVID Vaccines Had Similar Outcomes as Unvaccinated: Study
Jan 02
|